Recent functional work demonstrated that ATP13A3 mRNA is expressed in PASMCs, whilst loss of ATP13A3 inhibits endothelial cell proliferation and increases apoptosis, consistent with disease initiation models in PAH [10]. Here, ATP13A3 is linked to pulmonary arterial hypertension.